Overview

DANIPHARM AS is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering LACTULOSE CONCENTRATE.

API / Drug Master Files

DANIPHARM AS holds 1 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • LACTULOSE CONCENTRATEActive1990-09-20
  • LACTULOSE PURUM LIQUIDUMInactive2005-06-01

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to DANIPHARM AS in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.